Since it is difficult to identify and quantify the TLS structures in NSCLC by histological examination, we thought it is important to develop a representative biomarker that can be identified from the bulk RNA sequencing, in which CXCL13 expression can be a potential candidate. The gene discussed is CXCL13; the disease is non-small cell lung carcinoma.